COVID-19 Vaccines and Treatments

  • 2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines (Posted 10/25/21)
    CDC Clinician Outreach and Communication Activity (COCA) Webinar on Thursday, September 9, 2021. At the conclusion of today’s session, the participant will be able to accomplish the following— 1. Outline updates on the Advisory Committee on Immunization Practices recommendations for 2021-22 influenza vaccination season. 2. Discuss general influenza vaccination guidance during the COVID-19 pandemic. 3. Describe clinical considerations and best practices for coadministration of influenza vaccines and COVID-19 vaccines.
  • Acknowledgement of Compliance for Staff with Vaccination Exemption v1 (Posted 1/25/22)
    Unvaccinated employees due to a medical or religious exemption acknowledge that they must agree to abide by all Community Infection Prevention/Infection Control rules to protect the safety of residents and other staff in the community.
  • Adverse Events Reported After COVID-19 Vaccination (Released 3/9/21)
    CDC and FDA scientists have evaluated reports from people who experienced a type of severe allergic reaction, anaphylaxis, after getting a COVID-19 vaccine. Anaphylaxis after COVID-19 vaccination is rare and occurred in approximately 2 to 5 people per million vaccinated in the United States based on events reported to VAERS. This kind of allergic reaction almost always occurs within 30 minutes after vaccination. Fortunately, vaccination providers have medicines available to effectively and immediately treat patients who experience anaphylaxis following vaccination.
  • AHCA/NCAL COVID-19 Facility Vaccine Clinic Checklist v1 (Created 12/14/20)
    AHCA/NCAL has created the checklist for use when administering vaccines.
  • AHRQ Vaccination Tracking Toolkit 2022 (Posted 2/11/22)
    Vaccination Administration Records from AHRQ with instructions on how to use them.
  • AMDA COVID-19 Booster Shot Fact Sheet (Posted 1/11/22)
    Information on the COVID booster shot from AMDA.
  • AMDA Letter To Families COVID Vaccine (Released 12/23/20)
    The Society for Post-Acute and Long-Term Care Medicine have provided a letter that facilities can use to inform families about the safety of the COVID-19 vaccines.
  • AMDA - Q&A about the COVID-19 Vaccine for PALTC Patients Family Member and Staff Dec 1, 2020
    The Society for Post-Acute and Long-Term Care Medicine has released a Q&A about the COVID-19 vaccine.
  • ASPR TRACIE Planning Considerations for Monoclonal Antibody Administration (posted 8/11/21)
    Tip sheet from TRACIE updated February 10, 2021.
  • Assessment and Testing - Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance (Posted 7/15/21)
    Before ordering laboratory testing for post-COVID conditions, the goals of testing should be clear to the healthcare professional and to the patient. Laboratory testing should be guided by the patient history, physical examination, and clinical findings.